Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders
- PMID: 37055898
- DOI: 10.2174/1871527322666230412105711
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders
Abstract
Anxiety is a common mental illness that affects a large number of people around the world, and its treatment is often based on the use of pharmacological substances such as benzodiazepines, serotonin, and 5-hydroxytyrosine (MAO) neurotransmitters. MAO neurotransmitters levels are deciding factors in the biological effects. This review summarizes the current understanding of the MAO system and its role in the modulation of anxiety-related brain circuits and behavior. The MAO-A polymorphisms have been implicated in the susceptibility to generalized anxiety disorder (GAD) in several investigations. The 5-HT system is involved in a wide range of physiological and behavioral processes, involving anxiety, aggressiveness, stress reactions, and other elements of emotional intensity. Among these, 5-HT, NA, and DA are the traditional 5-HT neurons that govern a range of biological activities, including sleep, alertness, eating, thermoregulation, pains, emotion, and memory, as anticipated considering their broad projection distribution in distinct brain locations. The DNMTs (DNA methyltransferase) protein family, which increasingly leads a prominent role in epigenetics, is connected with lower transcriptional activity and activates DNA methylation. In this paper, we provide an overview of the current state of the art in the elucidation of the brain's complex functions in the regulation of anxiety.
Keywords: Anxiety; epigenetics; mitochondrial dysfunction; monoamine oxidase; oxidative stress.; papez circuit.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.J Neural Transm (Vienna). 2016 Feb;123(2):91-106. doi: 10.1007/s00702-014-1362-4. Epub 2015 Jan 22. J Neural Transm (Vienna). 2016. PMID: 25604428 Review.
-
Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.Int Rev Neurobiol. 2011;100:13-42. doi: 10.1016/B978-0-12-386467-3.00002-9. Int Rev Neurobiol. 2011. PMID: 21971001 Free PMC article. Review.
-
Regulation of monoamine oxidase A by the SRY gene on the Y chromosome.FASEB J. 2009 Nov;23(11):4029-38. doi: 10.1096/fj.09-139097. Epub 2009 Aug 6. FASEB J. 2009. PMID: 19661285 Free PMC article.
-
Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression.J Biol Chem. 2012 Jul 13;287(29):24195-206. doi: 10.1074/jbc.M112.373936. Epub 2012 May 24. J Biol Chem. 2012. PMID: 22628545 Free PMC article.
-
Drugs related to monoamine oxidase activity.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Aug 1;69:112-24. doi: 10.1016/j.pnpbp.2016.02.012. Epub 2016 Mar 2. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 26944656 Review.
Cited by
-
Amomum tsao-ko crevost et lemaire ameliorates depression-like behaviors and hippocampal inflammation by inhibiting microglia activation and HMGB1/TLR4/NF-κB pathway in diabetic mice with depression.Metab Brain Dis. 2025 Mar 28;40(4):164. doi: 10.1007/s11011-025-01592-z. Metab Brain Dis. 2025. PMID: 40153044
-
Atypical antipsychotic drug olanzapine inhibits 5-HT3 receptor-mediated currents by allosteric and non-competitive mechanisms.Korean J Physiol Pharmacol. 2025 Jul 1;29(4):431-442. doi: 10.4196/kjpp.24.340. Epub 2024 Dec 18. Korean J Physiol Pharmacol. 2025. PMID: 39690469 Free PMC article.
-
Resveratrol: A Multifaceted Guardian against Anxiety and Stress Disorders-An Overview of Experimental Evidence.Nutrients. 2024 Aug 26;16(17):2856. doi: 10.3390/nu16172856. Nutrients. 2024. PMID: 39275174 Free PMC article. Review.
References
-
- Hardiman O.; Al-Chalabi A.; Chio A.; Amyotrophic Lateral Sclerosis. Nat Rev Dis Primers 2017,31(3),1-19
-
- Gordon R.P.; Brandish E.K.; Baldwin D.S.; Anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder. Medicine 2016,44(11),664-671 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical